How we helped an established hemophilia player optimize its market access, pricing and reimbursement strategies in the US and EU5 markets.
The Challenge: How can an established player adapt its market access and…
How LucidQuest helped a company in the hemophilia space enhance its position in the market
The Challenge: How to unveil competitors' plans and gain a strategic edge A…
How LucidQuest Supported a leading pharma in Hemophilia to better position its Hemophilia A assets vs. a key competitor in the US
The Challenge: How can a Top-20 Pharma company uncover the key competitor's…
How a pharma in the digital respiratory space assessed its market positioning and refined its GTM strategy.
The Challenge: How to understand the go-to-market (GTM) strategies of key…
How LucidQuest helped a company in the depression space face its competition by delivering a workshop
The Challenge: How to develop effective counter-strategies in the depression…
How we supported a CNS mid-size pharma to better understand a new competitor and safeguard its position in the EU
The challenge: Understanding the impact of a new entrant on existing business A…
How a leading pharma company stayed updated with the latest solid tumors early stage advancements presented at AACR
The Challenge: Capturing the latest developments in the solid tumors space…
How a top-20 Pharma company gained competitive intelligence to formulate its market access strategy in the antibiotics market in Taiwan
The Challenge: Finding out the key competitor’s launch plan A Top-20 Pharma…
How we helped a Top-10 Pharma leverage its opportunities in the flu vaccine market in China and Korea.
The Challenge: Understanding the flu vaccine market landscape in China and…
How we helped a large-size Pharma prepare its sales and medical teams to beat a competitor launch of a new schizophrenia medication.
The Challenge: Gaining insights into competitor's new schizophrenia medication…
How we helped a Top-20 Pharma competitively position its asset in the oncology biosimilars’ space.
The challenge: Strategically positioning an asset in the oncology biosimilars…
How we ensured a Top-20 Pharma never missed the latest clinical / R&D and market-related updates in the Multiple Sclerosis space.
The Challenge: Staying updated with the latest advancements in the Multiple…